We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GC Medical Science corp.

Download Mobile App




New Scoring System Accurately Identifies HFpEF Heart Failure Patients

By HospiMedica International staff writers
Posted on 01 Aug 2024

Heart Failure with Preserved Ejection Fraction (HFpEF) is the fastest-growing type of heart failure. Diagnosing HFpEF across populations is notably challenging, particularly in primary care, due to the various factors that influence each patient's diagnosis. Many patients with HFpEF remain unidentified until their condition has substantially worsened. The diagnosis and management of HFpEF differ markedly from other types of heart failure, underscoring the importance of early detection and treatment to benefit from new therapies. Now, a newly developed scoring system has demonstrated effectiveness in identifying patients with HFpEF.

In collaborative research led by University Hospitals Harrington Heart & Vascular Institute (Cleveland, OH, USA), a team developed the HFpEF-ABA score which integrates factors such as age, body mass index (BMI), and atrial fibrillation to facilitate the diagnosis of HFpEF, particularly in patients presenting with unexplained dyspnea or shortness of breath. The HFpEF score was derived and validated using data pooled from prominent academic centers across Australia, Belgium, Denmark, Japan, the Netherlands, and the United States. It calculates the likelihood of HFpEF based on three simple clinical parameters: age, BMI, and atrial fibrillation, according to research published on July 12 in Nature Medicine.

The simplicity of the HFpEF-ABA score makes it a practical tool for initial screening without the need for advanced imaging, thereby extending its applicability to various healthcare settings, including those in primary care and remote locations. Patients identified through this screening as having a high probability of HFpEF could be directed towards further diagnostic procedures such as echocardiography or cardiac catheterization as necessary. Moreover, it allows for the prompt initiation of treatment with novel medications like SGLT-2 inhibitors (SGLT-2i) and GLP-1 receptor agonists (GLP-1RA), enhancing patient outcomes. The researchers acknowledge a significant segment of the population likely remains undiagnosed with HFpEF. Ongoing studies aim to explore effective strategies to promote the adoption of this new scoring system among clinicians, facilitating the timely identification and appropriate management of patients with HFpEF using the latest therapeutic options.

“We’re tapping into an opportunity to elevate the standard of care, and it will change the paradigm for diagnosis for better identification of HFpEF at the community level,” said Varun Sundaram, MD, PhD, MSc, FRCP (UK). "By improving our ability to identify these patients, physicians can respond more quickly and effectively to treat their specific conditions. The new score was designed to address this need. It is a straightforward scoring model that has demonstrated excellent performance across diverse populations."

Related Links:
University Hospitals Harrington Heart & Vascular Institute

Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
New
Mobile Cart
MS550
New
Video Uretero-Renoscope
Olympus URF-V3/V3R
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The Elana Heart Bypass System is designed to make suturing obsolete (Photo courtesy of AMT Medical)

Pioneering Sutureless Coronary Bypass Technology to Eliminate Open-Chest Procedures

In patients with coronary artery disease, certain blood vessels may be narrowed or blocked, requiring a stent or a bypass (also known as diversion) to restore blood flow to the heart. Bypass surgeries... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.